Yttrium-90 ibritumomab tiuxetan combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for relapsed/refractory B-cell non-Hodgkin's lymphoma

被引：4
|
作者：
Shimabukuro-Vornhagen, A. [1 ]
Josting, A. [1 ]
Huebel, K. [1 ]
Scheid, C. [1 ]
Dietlein, M. [1 ]
Engert, A. [1 ]
Schnell, R. [1 ]
机构：
[1] Univ Hosp Cologne, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.8615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8615
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Gordon, LI
    Witzig, TE
    Wiseman, GA
    Flinn, IW
    Spies, SS
    Silverman, DH
    Emmanuolides, C
    Cripe, L
    Saleh, M
    Czuczman, MS
    Olejnik, T
    White, CA
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 87 - 92
  • [42] Yttrium-90-ibritumomab tiuxetan radioimmunotherapy - A new treatment approach for B-cell non-Hodgkin's lymphoma
    Witzig, TE
    DRUGS OF TODAY, 2004, 40 (02): : 111 - 119
  • [43] A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma
    Nademanee, A
    Forman, S
    Molina, A
    Fung, H
    Smith, D
    Dagis, A
    Kwok, C
    Yamauchi, D
    Anderson, AL
    Falk, P
    Krishnan, A
    Kirschbaum, M
    Kogut, N
    Nakamura, R
    O'Donnell, M
    Parker, P
    Popplewell, L
    Pullarkat, V
    Rodriguez, R
    Sahebi, F
    Smith, E
    Snyder, D
    Stein, A
    Spielberger, R
    Zain, J
    White, C
    Raubitschek, A
    BLOOD, 2005, 106 (08) : 2896 - 2902
  • [44] High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
    Alkhaldi, Hanan
    Reinhardt, Alec
    Barnett, Melissa
    Kundu, Suprateek
    Hosing, Chitra
    Ramdial, Jeremy
    Saini, Neeraj
    Srour, Samer
    Alousi, Amin
    Kebriaei, Partow
    Popat, Uday
    Qazilbash, Muzaffar
    Champlin, Richard
    Shpall, Elizabeth J.
    Gulbis, Allison
    Shigle, Terri Lynn
    Dabaja, Bouthaina
    Pinnix, Chelsea
    Ahmed, Sairah
    Steiner, Raphael
    Andersson, Borje S.
    Nieto, Yago
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 690 - 694
  • [45] High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
    Rancea, Michaela
    Monsef, Ina
    von Tresckow, Bastian
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [46] A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma
    Shimoni, Avichai
    Avivi, Irit
    Rowe, Jacob M.
    Yeshurun, Moshe
    Levi, Itai
    Or, Reuven
    Patachenko, Paulina
    Avigdor, Abraham
    Zwas, Tzila
    Nagler, Arnon
    CANCER, 2012, 118 (19) : 4706 - 4714
  • [47] High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma
    Vose, JM
    ANNALS OF ONCOLOGY, 1998, 9 : 1 - 3
  • [48] BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients
    Kim, J.
    Kim, E.
    Sohn, B.
    Yoon, D.
    Yoo, C.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] BEAM OR BUCYE HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA PATIENTS
    Suh, C.
    Kim, J. E.
    Sohn, B. S.
    Yoon, D. H.
    Lee, D. H.
    Kim, S. W.
    Lee, J. S.
    Kim, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 643 - 643
  • [50] Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with 90Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation
    Wondergem, Marielle J.
    Zijlstra, Josee M.
    de Rooij, Madelon
    Visser, Otto J.
    Huijgens, Peter C.
    Zweegman, Sonja
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (03) : 395 - 397
12345